Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocugen (OCGN) Change in Accured Expenses: 2014-2025

Historic Change in Accured Expenses for Ocugen (OCGN) over the last 12 years, with Sep 2025 value amounting to $3.3 million.

  • Ocugen's Change in Accured Expenses rose 52.20% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year increase of 3819.63%. This contributed to the annual value of $4.1 million for FY2024, which is 133.52% up from last year.
  • As of Q3 2025, Ocugen's Change in Accured Expenses stood at $3.3 million, which was up 57.82% from $2.1 million recorded in Q2 2025.
  • Over the past 5 years, Ocugen's Change in Accured Expenses peaked at $3.9 million during Q3 2022, and registered a low of -$5.0 million during Q1 2023.
  • In the last 3 years, Ocugen's Change in Accured Expenses had a median value of -$1.4 million in 2023 and averaged -$554,636.
  • Per our database at Business Quant, Ocugen's Change in Accured Expenses skyrocketed by 21,460.00% in 2021 and then tumbled by 3,889.31% in 2023.
  • Ocugen's Change in Accured Expenses (Quarterly) stood at $573,000 in 2021, then skyrocketed by 380.45% to $2.8 million in 2022, then slumped by 170.50% to -$1.9 million in 2023, then skyrocketed by 207.62% to $2.1 million in 2024, then soared by 52.20% to $3.3 million in 2025.
  • Its last three reported values are $3.3 million in Q3 2025, $2.1 million for Q2 2025, and -$3.3 million during Q1 2025.